Research (Jan 2024)

Integrating Single-Cell and Spatial Transcriptomics to Uncover and Elucidate GP73-Mediated Pro-Angiogenic Regulatory Networks in Hepatocellular Carcinoma

  • Jiazhou Ye,
  • Xing Gao,
  • Xi Huang,
  • Shilin Huang,
  • Dandan Zeng,
  • Wenfeng Luo,
  • Can Zeng,
  • Cheng Lu,
  • Lu Lu,
  • Hongyang Huang,
  • Kaixiang Mo,
  • Julu Huang,
  • Shizhou Li,
  • Minchao Tang,
  • Tianzhun Wu,
  • Rongyun Mai,
  • Min Luo,
  • Mingzhi Xie,
  • Shan Wang,
  • Yongqiang Li,
  • Yan Lin,
  • Rong Liang

DOI
https://doi.org/10.34133/research.0387
Journal volume & issue
Vol. 7

Abstract

Read online

Hepatocellular carcinoma (HCC) was characterized as being hypervascular. In the present study, we generated a single-cell spatial transcriptomic landscape of the vasculogenic etiology of HCC and illustrated overexpressed Golgi phosphoprotein 73 (GP73) HCC cells exerting cellular communication with vascular endothelial cells with high pro-angiogenesis potential via multiple receptor–ligand interactions in the process of tumor vascular development. Specifically, we uncovered an interactive GP73-mediated regulatory network coordinated with c-Myc, lactate, Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) pathway, and endoplasmic reticulum stress (ERS) signals in HCC cells and elucidated its pro-angiogenic roles in vitro and in vivo. Mechanistically, we found that GP73, the pivotal hub gene, was activated by histone lactylation and c-Myc, which stimulated the phosphorylation of downstream STAT3 by directly binding STAT3 and simultaneously enhancing glucose-regulated protein 78 (GRP78)-induced ERS. STAT3 potentiates GP73-mediated pro-angiogenic functions. Clinically, serum GP73 levels were positively correlated with HCC response to anti-angiogenic regimens and were essential for a prognostic nomogram showing good predictive performance for determining 6-month and 1-year survival in patients with HCC treated with anti-angiogenic therapy. Taken together, the aforementioned data characterized the pro-angiogenic roles and mechanisms of a GP73-mediated network and proved that GP73 is a crucial tumor angiogenesis niche gene with favorable anti-angiogenic potential in the treatment of HCC.